What sector does Lincoln Pharmaceuticals Limited (LINCOLN) operate in?
Lincoln Pharmaceuticals Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Lincoln Pharmaceuticals Limited (LINCOLN) current stock price?
As of the latest data, Lincoln Pharmaceuticals Limited stock price is ₹550.65, with a previous close of ₹564.35. Lincoln Pharmaceuticals Limited lost -₹13.70 in the last trading session, representing a -2.43% loss.
What is Lincoln Pharmaceuticals Limited (LINCOLN) current market capitalization?
Lincoln Pharmaceuticals Limited market cap is approximately 11.03 billion.
What is Lincoln Pharmaceuticals Limited (LINCOLN) Earnings Per Share (EPS)?
The trailing EPS is ₹44.59.
What is Lincoln Pharmaceuticals Limited (LINCOLN) Price-to-Earnings (P/E) ratio?
Lincoln Pharmaceuticals Limited current P/E ratio is 12.35.
What is Lincoln Pharmaceuticals Limited (LINCOLN) EBITDA?
Lincoln Pharmaceuticals Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 326.33 million.
Does Lincoln Pharmaceuticals Limited (LINCOLN) dividends?
Yes. Lincoln Pharmaceuticals Limited pays annual dividends with a forward yield of 0.33% and a forward payout of ₹1.80 per share.
When is the next ex-dividend date for Lincoln Pharmaceuticals Limited (LINCOLN)?
The next ex-dividend date is scheduled for September 13, 2025.
When is Lincoln Pharmaceuticals Limited (LINCOLN) next earnings report?
Lincoln Pharmaceuticals Limited is expected to release its next earnings report on March 31, 2025.
What is Lincoln Pharmaceuticals Limited (LINCOLN) beta (volatility) score?
Lincoln Pharmaceuticals Limited has a beta of 0.411, indicating lower volatility than the overall market.